Clinical Trial Update: Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN) [Phase 3]

View source ↗

Summary

Phase 3 trial update on mycophenolate mofetil (MMF) for IgA nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Sun Yat-sen University | Conditions: IgA Nephropathy | Phase 3 | Status: COMPLETED